glp-1 incretin hormones and the satiation signal Incretin & Hormone Receptor Agonists

More common short-term discomforts include nausea, vomiting, diarrhea, and abdominal pain

For example, in the lungs, GLP-1s may reduce the inflammatory response, improve oxidative stress, regulate protease/anti-protease imbalance, improve airway mucus homeostasis and reduce airway remodeling to provide benefit in patients with COPD

What to Expect When Microdosing GLP-1 Since titration (gradually increasing the dose) is slower with microdosing, the overall timeline often looks different than standard protocols

GLP-1 drugs are indicated for patients with obesity, i.e

Nat Commun 11(1):1896

Combining it with other metabolic drugs should only occur under medical supervision